A Study to Assess the Steady-State Bioequivalence of Once-Weekly Corplex™ 10mg Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2018
At a glance
- Drugs Donepezil (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Pharmacokinetics; Registrational
- Sponsors Corium International
- 31 Jul 2018 Status changed to completed.
- 14 May 2018 According to a Corium International media release, based on this study, the company is planning to a submission of a Section 505(b)(2) New Drug Application (NDA) in the first quarter of 2019.
- 24 Apr 2018 Planned End Date changed from 1 Aug 2018 to 1 Dec 2018.